Company intelligence / Profile preview
EURRUS Biotech GmbH
Tulln, Austria
- Ownership
- Private
- Development stage
- Other
01
Overview
EURRUS Biotech GmbH has developed an oral small molecule therapy, XC‑8, targeting the histamine receptor pathway for the treatment of mild and moderate asthma. The company completed successful Phase I trials in Austria and Germany and a pivotal Phase II trial at ten centers across Russia. Results showed high efficacy with no significant side effects. As of late 2020/2021, the lead asset was advancing into or pending Phase III clinical evaluation.
- Therapeutic areas
- Pulmonology
- Modalities
- Small molecules (notably oral small molecule drug XC-8)Potentially biologics (company claims expertise in both, but pipeline focus on small molecules)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Pharmenterprise LLC, Moscow – clinical partner for Russian studiesFGK Clinical Research, Munich – CRO partner for European studiesAcademic partners include Karl Landsteiner Institute (Vienna) and ITEM Hannover [Germany] for early phase trials
Beyond the preview
Go deeper on EURRUS Biotech GmbH.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EURRUS Biotech GmbH.